Oncoinvent announces positive interim results from phase 1/2a studies of Radspherin for treatment of peritoneal carcinomatosis: Oslo, Norway Tuesday, November 12, 2024, 18:00 Hrs ...

The 5-year OS rates were 46% in the HIPEC group versus 38% in the no-HIPEC group, they noted in Lancet Oncology. The trial ...

The multifocality and irregularity of peritoneal carcinomatosis complicates the within-lesion reproducibility of ADC measurements and the feasibility of accurate serial comparisons. Robust ...

There are plans to evaluate TPMs in patients with peritoneal metastases or carcinomatosis, including pancreatic and other gastrointestinal and ovarian cancers.

Dr. Lambert specializes in the care of patients requiring surgical treatment related to peritoneal carcinomatosis (cancer which has spread throughout the lining of the abdominal cavity) and ...

Researchers at University of California San Diego School of Medicine found an FDA-approved drug used to treat breast cancer ...

and the Peritoneal Metastasis Research Fund. Confocal imaging and histology core studies were performed with support from the UCSD Specialized Cancer Support Center P30 grant 2P30CA023100. The ...

stabilized tumor growth and reduced blood tumor marker levels in patients with peritoneal mucinous carcinomatosis (PMC). This form of cancer originates in the appendix and is often resistant to ...

Generalised eruptive keratoacanthoma of Grzybowski (GEKA) is a rare disease characterised by the sudden appearance of ...